Table 3 Demographic and clinical characteristics of study subjects (N = 567*)
Characteristic | Value |
|---|---|
Mean (SD) age, y | 52.3 (9.8) |
Number (%) women | 412 (72.7) |
Comorbidities (n [%]) | |
Connective tissue diseases | 104 (18.3) |
Congenital heart diseases | 23 (4.1) |
HIV/AIDS | 1 (0.2) |
Depressive disorders | 29 (5.1) |
Anxiety disorders | 8 (1.4) |
Sleep disorders | 83 (14.6) |
Lung disease | |
Asthma | 33 (5.8) |
Chronic obstructive pulmonary disease | 108 (19.0) |
Pulmonary fibrosis | 69 (12.2) |
Any of above | 172 (30.3) |
Cerebrovascular disease | 10 (1.8) |
Coronary heart disease | 68 (12.0) |
Atrial fibrillation | 46 (8.1) |
Congestive heart failure | 134 (23.6) |
Peripheral vascular disease | 9 (1.6) |
Hematological conditions | 8 (1.4) |
Liver disease | 44 (7.8) |
Renal disease | 72 (12.7) |
Diabetes | 91 (16.0) |
Neoplasms | 38 (6.7) |
Mean (SD) Charlson comorbidity index | 1.0 (1.1) |